eBooks & Guides

The biologics researcher's mini-guide to screening candidates with nanoDSF

Issue link: https://resources.nanotempertech.com/i/1498850

Contents of this Issue

Navigation

Page 8 of 15

However, no shi in T m2 (Fab/Fc2) and a very similar profile otherwise indicates that the conjugation process le the mAb otherwise intact The destabilizing shi in T m1 indicates that the small molecule drug is conjugated to the Fc1 domain F350/F330 .95 0.9 0.85 0.8 0.7 0.75 30 40 50 60 70 80 90 ADC naked mAb Temperature (°C) 0.025 0.015 0.010 0.005 -0.005 0.000 30 40 50 60 70 80 90 ADC naked mAb Temperature (°C) 0.020 100 20 The conjugation process o en introduces harsh or destabilizing conditions to an antibody that will have a negative impact on its long- term stability and developability. By comparing the thermal unfolding profiles of the final ADC candidate with the orginal, naked (unconjugated) mAb, you learn whether your therapeutic remained stable during the process, and even confirm the domain to which the drug conjugated. 100 First derivative

Articles in this issue

view archives of eBooks & Guides - The biologics researcher's mini-guide to screening candidates with nanoDSF